During the past decade, St. Luke's Hospital Cancer Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Hospital Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 38 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Hospital Cancer Center" are "Head and Neck Cancer" (7 trials), "Prostate Cancer" (7 trials), "Breast Cancer" (6 trials), "Lung Cancer" (6 trials) and "Brain and Central Nervous System Tumors" (5 trials). Many other conditions were trialed in "St. Luke's Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "St. Luke's Hospital Cancer Center" are "Drug" (55 trials), "Radiation" (40 trials), "Procedure" (29 trials), "Biological" (20 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (35 trials), "conventional surgery" (12 trials), "cisplatin" (11 trials), "paclitaxel" (9 trials) and "filgrastim" (8 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Hospital Cancer Center" are 61 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "St. Luke's Hospital Cancer Center". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in St. Luke's Hospital Cancer Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Hospital Cancer Center, 7 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".